BIOMAT Database Logo BIOMAT Database Logo

Lipoprotein(a) and familial hypercholesterolaemia. 2016

Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Department of Cardiology, Hospital Clínico San Carlos, IDISSC, Universidad Complutense, Madrid, Spain; Fundación Hipercolesterolemia Familiar, 28010 Madrid, Spain. Electronic address: leopisla@hotmail.com.

UI MeSH Term Description Entries
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Lipoprotein (a) in familial hypercholesterolaemia.
August 2022, Current opinion in lipidology,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Familial hypercholesterolaemia: beware of lipoprotein(a).
July 2016, The lancet. Diabetes & endocrinology,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Lipoprotein(a) and familial hypercholesterolaemia - Authors' reply.
September 2016, The lancet. Diabetes & endocrinology,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Lipoprotein (a) and coronary heart disease in familial hypercholesterolaemia.
August 1988, Lancet (London, England),
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Increased lipoprotein(a) levels in children with familial hypercholesterolaemia.
November 1988, Lancet (London, England),
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Lipoprotein(a) levels in patients with homozygous familial hypercholesterolaemia.
July 2001, Atherosclerosis,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia: implication for lipoprotein(a) metabolism.
August 1994, The Clinical investigator,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a).
December 2017, European heart journal,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Carotid atherosclerosis and lipoprotein particle subclasses in familial hypercholesterolaemia and familial combined hyperlipidaemia.
July 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Leopoldo Pérez de Isla, and Adriana Saltijeral Cerezo, and Rodrigo Alonso, and Pedro Mata
Lipoprotein(a) and subclinical vascular disease progression in children with familial hypercholesterolaemia.
September 2023, The lancet. Diabetes & endocrinology,
Copied contents to your clipboard!